Entity Details

Primary name CYP17A1
Entity type gene
Source Source Link

Details

PrimaryID1586
RefseqGeneNG_007955
SymbolCYP17A1
Namecytochrome P450 family 17 subfamily A member 1
Chromosome10
Location10q24.32
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1993-01-14
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsCP17A_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004508 steroid 17-alpha-monooxygenase activity
GO:0005506 iron ion binding
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0006694 steroid biosynthetic process
GO:0006702 androgen biosynthetic process
GO:0006704 glucocorticoid biosynthetic process
GO:0007548 sex differentiation
GO:0008202 steroid metabolic process
GO:0019825 oxygen binding
GO:0020037 heme binding
GO:0042446 hormone biosynthetic process
GO:0042448 progesterone metabolic process
GO:0047442 17-alpha-hydroxyprogesterone aldolase activity

Diseases

Show/Hide Table
Disease IDSourceNameDescription
202110 OMIMAdrenal hyperplasia 5 (AH5)A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic). The disease is caused by variants affecting the gene represented in this entry.